1 week Ago
Pacific Biosciences of California, Inc. ( NASDAQ: PACB ) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Todd Friedman - Senior Director of Investor Relations Christian Henry - President and Chief Executive Officer Susan Kim - Chief Financial Officer Conference Call Participants Kyle Mikson - Canaccord Genuity Corp. Daniel Brennan - TD Cowen Doug Schenkel - Wolfe Research Sung Ji Nam - Scotiabank Tejas Savant - Morgan Stanley Operator Hello and welcome to the PacBio First Quarter 2024 Earnings Conference Call.
All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] As a reminder this conference is being recorded.
I would now like to hand the call to Todd Friedman, Senior Director of Investor Relations. Please go ahead. Todd Friedman Good afternoon, and welcome to PacBio's first quarter 2024 earnings conference call.
Earlier today, we issued a press release outlining the financial results, we will be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com or as furnished on Form 8-K available on the Securities and Exchange Commission website at www.
sec.gov. A copy of our earnings presentation is also available on the Investor section of our website at www.
pacb.com. With me today are Christian Henry, President and Chief Executive Officer; and Susan Kim, Chief Financial Officer.
On.
